Search Within

Sloan Kettering Institute Faculty

Formats
  1. Journal Article (10886)
  2. Meeting Abstract (3786)
  3. Book Section (323)
  4. Review (252)
  5. Conference Paper (207)
  6. Editorial (149)
  7. Research Letter (43)
  8. Book Whole (34)
  9. Miscellaneous (21)
  10. Correspondence (17)
  11. Guidelines (6)
Groups
  1. GSK Faculty (11541)
  2. Molecular Pharmacology and Chemistry Program Faculty (7510)
  3. Department of Medicine (4941)
  4. Center for Molecular Imaging and Biotechnology (CMIB) (4526)
  5. Sloan Kettering Institute Postdocs (3537)
  6. Center for Hematologic Malignancies (3363)

More Groups

People
  1. Murray Brennan (1059)
  2. Steven Larson (959)
  3. Richard O'Reilly (748)
  4. Peter Scardino (671)
  5. Marcel Van Den Brink (618)
  6. Michel Sadelain (586)

More People

Years
  1. 2025 (178)
  2. 2024 (327)
  3. 2023 (367)
  4. 2022 (431)
  5. 2021 (455)
  6. 2020 (475)

More Years

Publications
  1. Blood (1057)
  2. Cancer Research (580)
  3. Journal of Clinical Oncology (392)
  4. Journal of Nuclear Medicine (387)
  5. Journal of Biological Chemistry (370)
  6. Proceedings of the National Academy of Sciences of the United States of America (369)

More Publications

Publishers
  1. Nature Publishing Group (1508)
  2. Elsevier Inc. (1399)
  3. American Association for Cancer Research (1174)
  4. American Society of Hematology (1075)
  5. Cell Press (1025)
  6. Wiley Blackwell (611)

More Publishers

Results (15724)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Cancer biology of molecular imaging
    Book Section

    Larson, S. M.
    In Volterrani, D.; Erba, P. A.; Strauss, H. W.; Mariani, G.; Larson, S. M. (Eds.) Nuclear Oncology: From Pathophysiology to Clinical Applications. 3rd ed (2022)

    Fulltext@MSK | Save
  • Immune checkpoint blockade enhances cyclophosphamide induced anti-tumor immunity in a preclinical melanoma model
    Meeting Abstract

    George, M.; Betof, A.; Merghoub, T.; Hamadene, L.; Hirschhorn, D.; Houghton, A.; Wolchok, J.
    Journal for ImmunoTherapy of Cancer (2022)

    Fulltext@MSK | Save
  • LDH inhibition improves response to CTLA-4 blockade by enhancing effector T cell activity and impairing regulatory T cell suppression
    Meeting Abstract

    Verma, S.; Serganova, I.; Budhu, S.; Dong, L.; Mangarin, L.; Ko, M.; Blasberg, R.; Zappasodi, R.; Wolchok, J.; Merghoub, T.
    Journal for ImmunoTherapy of Cancer (2022)

    Fulltext@MSK | Save
  • Epigenetic dysregulation from chromosomal transit in micronuclei
    Meeting Abstract

    Agustinus, A. S.; Raviram, R.; Dameracharla, B.; Luebeck, J.; Stransky, S.; Scipioni, L.; Myers, R. M.; Di Bona, M.; Duran, M.; Weigelt, B.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Estrogen receptor expression and ER dependent breast tumor growth are dependent on translation initiation factor EIF4A
    Meeting Abstract

    Boyer, J. A.; Dorso, M. A.; Amor, C.; Reiter, J.; Xu, J.; de Stanchina, E.; Wendel, H. G.; Chandarlapaty, S.; Rosen, N.
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Multilineage plasticity in prostate cancer through expansion of stem-like luminal epithelial cells with elevated inflammatory signaling
    Meeting Abstract

    Zaidi, S.; Zhao, J.; Chan, J.; Martine, R.; Wadosky, K.; Gopalan, A.; Karthaus, W.; Watson, P.; True, L.; Nelson, P.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Frequent 4EBP1 amplification induces synthetic dependence on FGFR signaling in cancer
    Meeting Abstract

    Singh, K.; Mohan, P.; Sanghvi, V. R.; Ciriello, G.; Lailler, N.; de Stanchina, E.; Wendel, H. G.
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Tumor-intrinsic PRC2 inactivation drives a context-dependent immune-desert tumor microenvironment
    Meeting Abstract

    Yan, J.; Chen, Y.; Patel, A. J.; Lee, C. J.; Warda, S.; Nixon, B. G.; Wong, E. W. P.; Miranda-Román, M. A.; Yang, N.; Wang, Y.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save
  • A multi-omic perspective of how selection shapes blood cancer risk phenotypes in aging populations
    Meeting Abstract

    Skead, K.; Soave, D.; Faye, M. J.; Bruat, V.; Morris, Q.; Awadalla, P.
    Cancer Research (2022)

    Fulltext@MSK | Save
  • SMYD2 regulates chromatin modifier KMT2D in ER+/PIK3CA mutant breast cancer
    Meeting Abstract

    Blawski, R.; Sallaku, M.; Guo, X.; Kittane, S.; Scaltriti, M.; Luo, M.; Toska, E.
    Cancer Research (2022)

    Fulltext@MSK | Save